0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter | 
Kate Smolina, PhD; Deirdre Weymann, MA; Steve Morgan, PhD; et al.
JAMA. 2015;313(18):1861-1862. doi:10.1001/jama.2015.3642.

Viewpoint |  FREE ONLINE FIRST
Euan A. Ashley, MRCP, DPhil
JAMA. Published online April 30, 2015. doi:10.1001/jama.2015.3595

Original Investigation | 
Supriya Shore, MD; P. Michael Ho, MD, PhD; Anne Lambert-Kerzner, MSPH, PhD; et al.
JAMA. 2015;313(14):1443-1450. doi:10.1001/jama.2015.2761.
Includes: Supplemental Content

From the JAMA Network | 
Wilbert S. Aronow, MD
JAMA. 2015;313(13):1362-1363. doi:10.1001/jama.2015.248.

From the JAMA Network | 
Mark Olfson, MD, MPH
JAMA. 2015;313(12):1256-1257. doi:10.1001/jama.2014.15743.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2015;313(12):1199. doi:10.1001/jama.2015.2195.

The JAMA Forum |  FREE
Austin B. Frakt, PhD
JAMA. 2015;313(11):1091-1092. doi:10.1001/jama.2015.0544.

Original Investigation | 
Hongmei Nan, MD, PhD; Carolyn M. Hutter, MS, PhD; Yi Lin, MS; et al.
JAMA. 2015;313(11):1133-1142. doi:10.1001/jama.2015.1815.
Includes: Supplemental Content

Global Health | 
M. J. Friedrich
JAMA. 2015;313(11):1093. doi:10.1001/jama.2015.1096.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;313(10):1052-1053. doi:10.1001/jama.2015.1302.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Viewpoint  | 
The Reach of the 340B Drug Pricing Program
Joerg Albrecht, MD, PhD; Sukhraj Mudahar, PharmD, BCPS
JAMA Internal Medicine
Teachable Moment  | 
The Diagnostic Cascade of Incidental Findings:  A Teachable Moment
Linh T. Nguyen, BS; Christopher T. Sullivan, BA; Anil N. Makam, MD, MAS
JAMA Neurology
Viewpoint  | 
The Patient Protection and Affordable Care Act and Chronic Neurological Illnesses:  Benefits and Challenges
Gregory J. Esper, MD, MBA; Daniel Hartung, PharmD, MPH; Orly Avitzur, MD, MBA
JAMA Dermatology
Case Report/Case Series  | 
Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma
Cristina Carrera, MD, PhD; Joan A. Puig-Butillè, PhD; Gemma Tell-Marti, Ph; et al.